Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB25FC1GF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,715
Award facts
- Contract value 100% obligated
- $34,715.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,715 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on September 15, 2025, with an ultimate completion date of October 6, 2025, carries no set-aside designation. Nexplanon is a subdermal contraceptive implant used in military and federal healthcare systems. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026, which authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting medical supply needs across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure contracts with the Defense Logistics Agency for an extensive portfolio of prescription medications, biologics, and medical consumables. The company's contract history demonstrates consistent success in providing specialized pharmaceutical products ranging from contraceptive devices to oncology treatments and vaccines to military health facilities. The present delivery order reflects the company's ongoing role in supporting the Defense Logistics Agency's mission to supply essential medical products to Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FC1GF?
SPE2DB25FC1GF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FC1GF worth?
The government has obligated $34,715 on SPE2DB25FC1GF.
Is contract SPE2DB25FC1GF an order under another contract?
Yes. SPE2DB25FC1GF is a delivery order under SPE2DB20D9766, an indefinite delivery contract.
Was contract SPE2DB25FC1GF competed?
The extent of competition for SPE2DB25FC1GF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award